Ontology highlight
ABSTRACT: Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer
PROVIDER: PRJNA1040464 | ENA |
REPOSITORIES: ENA
ACCESS DATA